Biora Therapeutics, Inc. (PROG) Stock Analysis
DELISTED
What happened to Biora Therapeutics, Inc. (PROG) stock?
Biora Therapeutics, Inc. (PROG) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $8.18M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Biora Therapeutics, Inc. (PROG). Biora Therapeutics, Inc. is a biotechnology company focused on developing oral biotherapeutics and smart diagnostics for gastrointestinal diseases. Their innovative approach aims to improve drug delivery and diagnostic accuracy.
Last analyzed: May 10, 2026Biora Therapeutics, Inc. (PROG) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PROG shares?
No. PROG stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for PROG elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PROG stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Biora Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.